Diagnostic Testing in ER, OR & ICU Settings Reviewed

Rising economic constraints on hospitals, in tandem with developments in diagnostic products and technologies, tougher competition amid suppliers and physicians, and altering consumers’ requirements are moving diagnostic testing from hospitals nearer to patients.

In-demand research report “Diagnostic Testing in the US Ancillary Hospital Locations (ER, OR, ICU)” developed by Venture Planning Group (VPG) provides comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory worldwide with a focus on the United States.

The study provides a review of the dynamics, trends, structure, size, growth and major suppliers with respect to the three market segments –emergency rooms (ERs), operating/recovery suites (ORs) and intensive care units (ICUs).; offers five-year test volume and sales forecasts for chemistry, immunodiagnostic, microbiology, hematology and coagulation procedures by market segment and test category. Sales and market shares of major reagent and instrument suppliers are included. The research covers over 130 diagnostic procedures; reviews leading POC analyzers; examines emerging technologies and their applications for POC testing; comprehensively lists companies developing or marketing POC diagnostic technologies and products (by test); assesses top suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, JVs, and new products in RnD. Strategic recommendations are offered in the study as well.

The report can be found at: http://marketpublishers.com/report/life_sciences/diagnostics-diseases/diagnostic-testing-in-us-ancillary-hospital-locations-er-or-icu.html


Source: BusinessWire

Published on : Wed, 5 Jun 2013


Print as PDF
Rising economic constraints on hospitals, in tandem with developments in diagnostic products and technologies, tougher competition amid supplier

No comment


Please login to leave a comment...

Highlighted Products